GL1X · GenesisL1 explorer

Research workbench

CurF ER cyclopropanase from curacin A biosynthetic pathway

Analyse CurF ER cyclopropanase from curacin A biosynthetic pathway in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5DP2
Type
protein
Length
335 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
0.96
Source
Lyngbya majuscula
Molecule
CurF
UniProt
Q6DNE7
Ligands
NAP
Pockets
2 · best druggability 0.81

Structure

x-ray diffraction · resolution 0.96 · 1 distinct chain · 36% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACurFprotein33536% helix, 25% strandQ6DNE7

Ligands and binding sites

  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15610.810.8651NAP
21660.520.7929empty

Compared structures

  • 5DP2 · Curf er cyclopropanase from curacin a biosynthetic pathway · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.